The Royal College of Radiologists is delighted to hear NHS England has started treating patients at its new proton beam therapy facility, based at The Christie in Manchester.
Dr Jeanette Dickson, RCR Vice-President of Clinical Oncology said:
“The RCR welcomes the news that the NHS’ high energy proton beam therapy strategy has reached a significant milestone with The Christie successfully treating its first patients.
“It is vital that UK patients have access to this technology, which gives an internationally recognised standard of care for a particular range of rare cancers, most of which affect extremely young, vulnerable patients.
"The rolling out of proton beam therapy in the UK represents a new era in treatment technology, which has been eagerly awaited by the cancer care community as well as patients. It will undoubtedly benefit those patients with some of the rarest cancers, as well as meaning that patients and their families will soon not have to travel abroad to access treatment, regardless of their circumstance.
“Having proton beam capability in the UK means we will be able take part in ongoing clinical trials, enabling the oncology community to conduct much-needed research to measure the benefits of the therapy and widen its use.”